{
    "organizations": [],
    "uuid": "e504d96e1a9600086eea28d58f88a226fa9c418e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-fda-reports-quality-problems-for-d/brief-fda-reports-quality-problems-for-data-provided-by-iqvia-that-were-used-to-inform-estimates-for-some-controlled-substances-idUSFWN1SN0X5",
    "ord_in_thread": 0,
    "title": "BRIEF-FDA Reports Quality Problems For Data Provided By IQVIA That Were Used To Inform Estimates For Some Controlled Substances",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 16 (Reuters) -\n* FDA REPORTS QUALITY PROBLEMS FOR DATA PROVIDED BY THE FIRM IQVIA THAT WERE USED TO INFORM ESTIMATES FOR SOME CONTROLLED SUBSTANCES\n* FDA-FOUND DISCREPANCY IN IQVIA DATA THAT SHOWED MORE THAN 20 PERCENT DROP IN REPORTED AMOUNT(KG)OF FENTANYL SOLD FOR A MINIMUM OF PAST FIVE YEARS COMPARED TO PREVIOUSLY REPORTED FIGURE\n* FDA SAYS BASED ON ITS INVESTIGATION, IT FOUND THAT PAST DATA WERE OVERESTIMATED BY IQVIA BECAUSE OF AN ERROR IN IQVIA’S METHODS\n* FDA-CALLED UPON IQVIA TO IMMEDIATELY RETAIN THIRD PARTY AUDITOR TO CONDUCT REVIEW OF DATA QUALITY, QUALITY CONTROL PROCEDURES OF CONTROLLED SUBSTANCE DATA UTILIZED BY FDA\n* FDA-WILL WORK WITH OTHER FEDERAL PARTNERS ON IQVIA’S ISSUES AND BRIEF MEMBERS OF CONGRESS ON IQVIA’S DATA QUALITY ISSUES, POTENTIAL PUBLIC HEALTH IMPLICATIONS\n* FDA-WANTS TO ASSESS WHETHER ERRORS WERE MORE SYSTEMATIC AND WIDESPREAD, WANTS TO DETERMINE THE POTENTIAL IMPACT OF SUCH ERRORS ON FDA’S WORK\n* FDA - ADDITIONAL DATA QUALITY ERRORS RAISE SERIOUS CONCERNS ABOUT SYSTEMIC ISSUES WITH IQVIA’S DATA AND QUALITY CONTROL PROCEDURES Source text: bit.ly/2ImqOK1 Further company coverage:\n ",
    "published": "2018-05-17T00:31:00.000+03:00",
    "crawled": "2018-05-17T14:45:20.005+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "fda",
        "report",
        "quality",
        "problem",
        "data",
        "provided",
        "firm",
        "iqvia",
        "used",
        "inform",
        "estimate",
        "controlled",
        "substance",
        "discrepancy",
        "iqvia",
        "data",
        "showed",
        "percent",
        "drop",
        "reported",
        "amount",
        "kg",
        "fentanyl",
        "sold",
        "minimum",
        "past",
        "five",
        "year",
        "compared",
        "previously",
        "reported",
        "figure",
        "fda",
        "say",
        "based",
        "investigation",
        "found",
        "past",
        "data",
        "overestimated",
        "iqvia",
        "error",
        "iqvia",
        "method",
        "upon",
        "iqvia",
        "immediately",
        "retain",
        "third",
        "party",
        "auditor",
        "conduct",
        "review",
        "data",
        "quality",
        "quality",
        "control",
        "procedure",
        "controlled",
        "substance",
        "data",
        "utilized",
        "fda",
        "work",
        "federal",
        "partner",
        "iqvia",
        "issue",
        "brief",
        "member",
        "congress",
        "iqvia",
        "data",
        "quality",
        "issue",
        "potential",
        "public",
        "health",
        "implication",
        "assess",
        "whether",
        "error",
        "systematic",
        "widespread",
        "want",
        "determine",
        "potential",
        "impact",
        "error",
        "fda",
        "work",
        "fda",
        "additional",
        "data",
        "quality",
        "error",
        "raise",
        "serious",
        "concern",
        "systemic",
        "issue",
        "iqvia",
        "data",
        "quality",
        "control",
        "procedure",
        "source",
        "text",
        "company",
        "coverage"
    ]
}